These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7039705)

  • 41. The pH dependent platelet utilization of arachidonic acid and a thromboxane A2 mimetic, in vitro.
    Kerry PJ; Paton CJ
    Pharmacol Res Commun; 1985 Jul; 17(7):609-18. PubMed ID: 3931104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of experimentally induced gastric damage with the tripeptide ZAMI-420, a new thromboxane synthesis inhibitor.
    Gervasi GB; Fossati A; Caliari S; Rapalli L; Bergamaschi M
    Int J Tissue React; 1983; 5(3):253-6. PubMed ID: 6418678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the mediator release from platelets and the development of acute inflammation in rats which lack prostaglandin precursors.
    Bult H; Bonta IL
    Agents Actions Suppl; 1977; 2():47-59. PubMed ID: 272843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries.
    Nakabayashi S; Uyama O; Nagatsuka K; Uehara A; Wanaka A; Yoneda S; Kimura K; Kamata T
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):323-32. PubMed ID: 3887528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The combined effects of 2,3-DPG and Na-arachidonate on platelet aggregation and on TXA2 formation.
    Iatridis PG; Hadd H; Kotrotsou M; Iatridis SG
    Thromb Res; 1986 Apr; 42(2):177-85. PubMed ID: 3087007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.
    Mais DE; Dunlap C; Hamanaka N; Halushka PV
    Eur J Pharmacol; 1985 Apr; 111(1):125-8. PubMed ID: 4018122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TxA2 production by human arteries and veins.
    Neri Serneri GG; Abbate R; Gensini GF; Panetta A; Casolo GC; Carini M
    Prostaglandins; 1983 Jun; 25(6):753-66. PubMed ID: 6414048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
    Mikhailidis DP; Jeremy JY; Barradas MA; Green N; Dandona P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1495-8. PubMed ID: 6416473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different sensitivity of basilar and saphenous arteries to thromboxane A2-induced contractions. Effect of imidazole 2-hydroxybenzoate (ITF 182).
    Pagella PG; Agozzino S; Bellavite O; Donà GC; Mendola N
    Arzneimittelforschung; 1984; 34(11):1514-6. PubMed ID: 6596952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre- and post-junctional actions of prostaglandin I2, carbocyclic thromboxane A2 and leukotriene C4 in dog tracheal tissue.
    Inoue T; Ito Y
    Br J Pharmacol; 1985 Feb; 84(2):289-98. PubMed ID: 2983807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Studies on the inhibitory effect of etafenone hydrochloride on platelet aggregation].
    Ujiie A; Komatsu H; Kubota T; Hamano S; Naito J
    Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):493-8. PubMed ID: 6618341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
    Bult H; Herman AG
    Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.